1. Home
  2. AQMS vs BCTX Comparison

AQMS vs BCTX Comparison

Compare AQMS & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

HOLD

Current Price

$8.05

Market Cap

21.2M

Sector

Industrials

ML Signal

HOLD

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$10.00

Market Cap

18.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AQMS
BCTX
Founded
2014
2014
Country
United States
Canada
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
18.5M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
AQMS
BCTX
Price
$8.05
$10.00
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$40.00
AVG Volume (30 Days)
260.6K
43.8K
Earning Date
11-12-2025
12-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$550.00
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.37
$6.00
52 Week High
$39.40
$190.50

Technical Indicators

Market Signals
Indicator
AQMS
BCTX
Relative Strength Index (RSI) 52.14 50.80
Support Level $7.25 $9.25
Resistance Level $8.28 $10.52
Average True Range (ATR) 0.79 0.80
MACD 0.16 0.19
Stochastic Oscillator 84.62 79.88

Price Performance

Historical Comparison
AQMS
BCTX

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: